Imvax

psych neuro brain
Biotech

Imvax takes brain cancer therapy to FDA despite missing primary

Imvax shrugged off the failure to hit its primary endpoint, reporting evidence of improved overall survival and making a beeline for the FDA.
Nick Paul Taylor Dec 2, 2025 8:00am
John Furey headshot

Imvax raises $112M to advance brain cancer cell therapy

Jul 16, 2020 8:00am